Six decades of vitiligo genetics: Genome-wide studies provide insights into autoimmune pathogenesis

Journal of Investigative Dermatology

Volumn 132, Issue 2, 2012, Pages 268-273

  Spritz, Richard A ^a  

^a Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPHIN LIKE PROTEIN 1; C1Q AND TUMOR NECROSIS FACTOR RELATED PROTEIN 6; CHEMOKINE RECEPTOR CCR6; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GRANZYME B; HLA A ANTIGEN; HLA ANTIGEN; HLA DQA1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LIM DOMAIN CONTAINING PREFERRED TRANSLOCATION PARTNER IN LIPOMA; LIM PROTEIN; LYMPHOID SPECIFIC PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR TYPE 22; MELANIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; NACHT LRR AND PYD DOMAIN CONTAINING PROTEIN 1; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN; THYMIC STROMAL LYMPHOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; TRANSCRIPTION FACTOR FOXP3; UBIQUITIN ASSOCIATED AND SH3 DOMAIN CONTAINING A; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ADDISON DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; AUTOSOMAL RECESSIVE INHERITANCE; CELIAC DISEASE; CELL DIFFERENTIATION; COMORBIDITY; CROHN DISEASE; CYTOTOXIC T LYMPHOCYTE; ENTERITIS; ETHNICITY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENERALIZED VITILIGO; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOCYTE; NATURAL KILLER CELL; PLASMA CELL; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

EID: 84855932497     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.321     Document Type: Review

References (65)

1. Addison T (1855) On the constitutional and local effects of disease of the suprarenal capsules. In: A collection of the published writing of the late Thomas Addison, M.D., physician to Guy's Hospital, New Sydenham Society, London 1868. Reprinted in Med Classics 1937 2:244-93
2. Alkhateeb A, Fain P, Spritz RA (2005) Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo. J Invest Dermatol 125:388-991
3. Alkhateeb A, Fain PR, Thody A et al. (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208-14 (Pubitemid 36597056)
4. Alkhateeb A, Stetler GL, Old W et al. (2002) Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 11:661-7 (Pubitemid 34285137)
5. Alkhateeb A, Qarqaz F (2010) Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs. Arch Dermatol Res 302: 631-4
6. Bhatia PS, Mohan L, Pandey ON et al. (1992) Genetic nature of vitiligo. J Dermatol Sci 4:180-4 (Pubitemid 23017815)
7. Birlea SA, Fain PR, Spritz RA (2008) A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch Dermatol 144:310-6 (Pubitemid 351439113)
8. Birlea SA, Gowan K, Fain PR et al. (2010) Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8. J Invest Dermatol 130:798-803
9. Birlea SA, Jin Y, Bennett DC et al. (2011a) Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol 131:371-81
10. Birlea SA, Spritz RA, Norris DA (2011b) Vitiligo. In: Fitzpatrick's Dermatology in General Medicine, (Wolff K, ed). 8th ed, New York: in press
11. Bishop TD, Demenais F, Iles MM et al. (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41:920-5
12. Boissy RE, Spritz RA (2009) Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff. Exp Dermatol 18:583-5
13. Chen JJ, Huang W, Gui JP et al. (2005) A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families. Am J Hum Genet 76:1057-65 (Pubitemid 40705439)
14. Claude H, Gourgerot H (1908) Insuffisiance pluriglandulaire endocrinienne. J Physiol Pathol Gen 10:469-80
15. Das SK, Majumder PP, Chakraborty R et al. (1985) Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 2:71-8 (Pubitemid 15101651)
16. De Iudicibus S, Stocco G, Martelossi S et al. (2011) Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases. J Clin Gastroenterol 45:e1-7
17. Dieudé P, Guedj M, Wipff J et al. (2010) NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis 70:668-74
18. Fain PR, Babu SR, Bennett DC et al. (2006) HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res 19:51-7
19. Fain PR, Gowan K, LaBerge GS et al. (2003) A genomewide screen for autoimmune vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 72:1560-4 (Pubitemid 36628395)
20. Freedman ML, Reich D, Penney KL et al. (2004) Assessing the impact of population stratification on genetic association studies. Nat Genet 36:388-93 (Pubitemid 38437262)
21. Gudbjartsson DF, Sulem P, Stacey SN et al. (2008) ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40:886-91 (Pubitemid 351913649)
22. Hirschhorn JN, Lohmueller K, Byrne E et al. (2002) A comprehensive review of genetic association studies. Genet Med 4:45-60
23. Howitz J, Brodthagen H, Schwartz M et al. (1977) Prevalence of vitiligo: epidemiological survey of the isle of Bornholm, Denmark. Arch Dermatol 113:47-52 (Pubitemid 8020128)
24. Jin Y, Birlea SA, Fain PR et al. (2010a) Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 362:1686-97
25. Jin Y, Birlea SA, Fain PR et al. (2010b) Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet 42:576-8
26. Jin Y, Birlea SA, Fain PR et al. (2011) Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol. 131:1308-12
27. Jin Y, Birlea SA, Fain PR et al. (2007a) Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 127:2558-62 (Pubitemid 47585070)
28. Jin Y, Mailloux CM, Gowan K et al. (2007b) NALP1 and vitiligo-associated multiple autoimmune disease. N Engl J Med 365:10-8
29. Johansson CM, Zunec R, Garcia MA et al. (2004) Chromosome 17p12-q11 harbors susceptibility loci for systemic lupus erythematosus. Hum Genet 115:230-8 (Pubitemid 39162204)
30. Kareemullah L, Taneja V, Begum S et al. (1977) Association of ABO blood groups and vitiligo. J Med Genet 14:211-3 (Pubitemid 8115918)
31. Kaser A, Lee AH, Franke A et al. (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134:743-56
32. Kim SM, Chung HS, Hann S-K (1998) The genetics of vitiligo in Korean patients. Internat J Dermatol 38:908-10 (Pubitemid 29012779)
33. Laberge G, Mailloux CM, Gowan K et al. (2005) Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 18:300-5 (Pubitemid 41032889)
34. Lamkanfi M, Dixit VM (2009) Inflammasomes: guardians of cytosolic sanctity. Immunol Rev 227:95-105
35. Lerner AB (1959) Vitiligo. J Invest Dermatol 32:285-310
36. Liang Y, Yang S, Zhou Y et al. (2007) Evidence for two susceptibility loci on chromosomes 22q12 and 6p21-p22 in Chinese generalized vitiligo families. J Invest Dermatol 127:2552-7 (Pubitemid 47585064)
37. Liu JB, Li M, Chen H et al. (2007) Association of vitiligo with HLA-A2: a meta-analysis. J Eur Acad Dermatol Venereol 21:205-13 (Pubitemid 46128696)
38. Magitta NF, Bøe Wolff AS, Johansson S et al. (2009) A coding polymorphism in NALP1 confers risk for autoimmune Addison0s disease and type 1 diabetes. Genes Immun 10:120-4
39. Majumder PP, Nordland JJ, Nath SP (1993) Pattern of familial aggregation of vitiligo. Arch Dermatol 129:994-8 (Pubitemid 23238604)
40. Mehta NR, Shah KC, Theodore C et al. (1973) Epidemiological study of vitiligo in Surat area, south Gujarat. Indian J Med Res 61:145-54
41. Mitchell MS, Harel W, Groshen S (1992) Association of HLA phenotype with response to active specific immunotherapy of melanoma. J Clin Oncol 10:1158-64
42. Nath SK, Kelly JA, Namjou B et al. (2001) Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 69:1401-6 (Pubitemid 33124222)
43. Neufeld M, Blizzard RM (1980) Polyglandular autoimmune diseases. In: Symposium on Autoimmune Aspects of Endocrine Disorders. (Pinchera A, Doniach D, Fenzi GF et al., eds). New York: pp 357-65
44. Nordlund JJ, Ortonne J-P, Le Poole IC (2006) Vitiligo vulgaris. In: The Pigmentary System (Nordlund JJ, Boissy RE, Hearing VJ et al., eds). 2nd ed, Oxford: Blackwell; pp 551-98
45. Obe WK (1984) Vitiligo in Zimbabwe. Cent Afr J Med 30:259-64
46. Picardo M, Ta?̈eb A (2010) eds. Vitiligo. Heidelberg: Springer
47. Pontillo A, Vendramin A, Catamo E et al. (2011) The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. Am J Gastroenterol 106:539-44
48. Quan C, Ren YQ, Xiang LH et al. (2010) Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 42:614-8
49. Ren Y, Yang S, Xu S et al. (2009) Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet 5:e1000523
50. Retornaz G, Betuel H, Ortonne JP et al. (1976) HL-A antigens and vitiligo. Br J Dermatol 95:173-5
51. Schmidt M (1926) Eine biglanduiare Erkrankung (Nebennieren und Schild-druse) bei Morbus Addisonii]. Verh Dtsch Ges Pathol 21:212-21
52. Skipper JCA, Hendrickson RC, Gulden PH et al. (1996) An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 183:527-34
53. Spritz RA (2008) The genetics of generalized vitiligo. Curr Dir Autoimmun 10:244-57
54. Spritz RA (2010) The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med 2:78
55. Spritz RA (2011) Recent progress in the genetics of generalized vitiligo. J Genet Genomics 38:271-8 (Pubitemid 47057312)
56. Spritz RA, Gowan K, Bennett DC et al. (2004) Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 74:188-91 (Pubitemid 38085251)
57. Stüttgen G (1950) Die Vitilgio in erbbiologischer Betrachtung]. Z Haut Geschlenkskr 9:451-6
58. Sun X, Xu A, Wei X et al. (2006) Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China. Int J Dermatol 45:1176-81 (Pubitemid 44560366)
59. Täeb A, Picardo M (2009) Vitiligo. N Engl J Med 360:160-9
60. Teindel H (1950) Familiäre. Z Haut Geschlenkskr 9:456-62
61. Toyofuku K, Wada I, Spritz RA et al. (2001) The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. Biochem J 355:259-69 (Pubitemid 32397783)
62. Tripathi RK, Flanders DJ, Young TL et al. (1999) Microphthalmia- associated transcription factor (MITF) locus lacks linkage to human vitiligo or osteopetrosis: an evaluation. Pigment Cell Res 12:187-92 (Pubitemid 129686280)
63. Tripathi RK, Giebel LB, Strunk KM et al. (1991) A polymorphism of the human tyrosinase gene that is associated with temperature-sensitive enzymatic activity. Gene Expr 1:103-10
64. Wasfi AI, Saha N, El Munshid HA et al. (1980) Genetic association in vitiligo: ABO, MNSs, Rhesus, Kell and Duffy blood groups. Clin Genet 17:415-7 (Pubitemid 10090131)
65. Zurawek M, Fichna M, Januszkiewicz-Lewandowska D et al. (2010) A coding variant in NLRP1 is associated with autoimmune Addison0s disease. Hum Immunol 71:530-4